RxDoctor Payments DataLook up a doctor →

Marshall Shoemaker, MD

Obstetrics & Gynecology · Fairhope, ALNPI 1659321065

Payments from drug & device makers

$9,612in general payments, 2019–2025

Across 323 payments — averaging $29.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$2K
  • Minerva Surgical, Inc$2K
  • AbbVie$849
  • Pfizer$530
  • Astellas Pharma US Inc$486
  • Mayne Pharma Commercial LLC$441
  • plus $4K from 44 others

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Coloplast9$2,126
Minerva Surgical, Inc2$1,599
AbbVie(2 entities)49$849
Pfizer29$530
Astellas Pharma US Inc15$486
Mayne Pharma Commercial LLC19$441
Therapeuticsmd, Inc.30$436
Sumitomo Pharma America, Inc.18$339
Bayer16$263
Eisai Inc.6$206
Endo Pharmaceuticals Inc.11$191
Novo Nordisk9$181
Urovant Sciences Inc7$133
Boston Scientific2$121
Mylan Pharmaceuticals Inc.6$115
Lilly USA, LLC8$112
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC6$107
Takeda Pharmaceuticals U.S.A., Inc.6$103
Bausch Health US, LLC5$91
Exeltis, USA Inc.5$80
Duchesnay USA Incorporated5$75
Currax Pharmaceuticals LLC5$75
Myovant Sciences Inc.5$72
Axsome Therapeutics, Inc.3$69
Mission Pharmacal Company4$62
Axonics, Inc.3$60
Hologic Sales And Service, LLC2$53
Daiichi Sankyo Inc.2$50
Baxter Healthcare2$46
Agile Therapeutics, Inc.3$46
Nalpropion Pharmaceuticals LLC3$39
Johnson & Johnson3$39
Millicent US Inc2$38
Mycovia Pharmaceuticals, Inc.2$37
Organon2$35
Vivus LLC2$34
Evofem Biosciences, Inc.2$33
Avion Pharmaceuticals2$27
AMAG Pharmaceuticals, Inc.2$27
Ascend Therapeutics US, LLC1$24
Merck1$23
Medtronic1$23
Roche Diagnostics Corporation1$20
Meditrina1$16
Ironwood Pharmaceuticals, Inc1$16
Olympus America Inc.1$15
Coopersurgical, Inc.1$14
IBSA Pharma Inc.1$13
Shire North American Group Inc1$12
Channel Medsystems, Inc.1$11

How this compares

$9,612 in reported general payments places this provider in the 90th percentile of 537 obstetrics & gynecology providers in Alabama.

See all obstetrics & gynecology providers in Alabama →

Medicare billing

Part B allowed, 2024
$52,329
Medicare patients
222
Services billed
1,438

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other obstetrics & gynecology in Fairhope

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →